TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 7 | 1 | -2 | 0 | -15 | -32 | -27 | -15 |
| S | %wins | 71 | 57 | 29 | 86 | 86 | 86 | 69 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/07 14:02 | 12/3/07 | AFFY | Affymax Inc | Health | Drug | Pharmaceutical Preparations | Naso Robert B | CA | O | EVP,Rese | S.d | -190 | 25.12 | 1 | -8 | -92 | 1 | D | -19 | -1 | -20 | -8 | -11 | -8 | -1 | -11 | -12 | -28 | -34 | -52 | |||
11/5/07 13:58 | 11/1/07 | AFFY | Affymax Inc | Health | Drug | Pharmaceutical Preparations | Naso Robert B | CA | O | EVP,Rese | S.d | -213 | 28.19 | 2 | -8 | -92 | 1 | D | -22 | 31 | 6 | -6 | -5 | -1 | -3 | 3 | -14 | -40 | -49 | -48 | |||
9/20/07 12:59 | 9/19/07 | AFFY | Affymax Inc | Health | Drug | Pharmaceutical Preparations | Naso Robert B | CA | O | EVP,Rese | S | -81 | 27.24 | 2 | -3 | -100 | 0 | D | -23 | -2 | 25 | 21 | 8 | -2 | 4 | 1 | 3 | -21 | -50 | -26 | |||
9/20/07 12:56 | 9/19/07 | AFFY | Affymax Inc | Health | Drug | Pharmaceutical Preparations | Naso Robert B | CA | O | EVP,Rese | S.d | -820 | 27.35 | 2 | -30 | -91 | 3 | D | -23 | -2 | 25 | 21 | 8 | -2 | 4 | 1 | 3 | -21 | -50 | -26 | |||
9/18/07 18:26 | 9/18/07 | AFFY | Affymax Inc | Health | Drug | Pharmaceutical Preparations | Naso Robert B | CA | O | EVP,Rese | S | -254 | 27.33 | 2 | -9 | -100 | 0 | D | -19 | -10 | 27 | 20 | 8 | -2 | 0 | -2 | 9 | -19 | -47 | -27 | |||
9/18/07 18:25 | 9/17/07 | AFFY | Affymax Inc | Health | Drug | Pharmaceutical Preparations | Naso Robert B | CA | O | EVP,Rese | S.dm | -440 | 27.49 | 2 | -16 | -63 | 9 | D | -19 | -10 | 27 | 20 | 8 | -2 | 0 | -2 | 9 | -19 | -47 | -27 | |||
11/3/03 18:42 | 10/30/03 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Naso Robert B | FL | O | SVP Qual | S | -658 | 11.36 | 6 | -58 | -86 | 10 | D | 37 | 86 | 61 | 97 | 27 | -8 | 1 | 1 | 0 | -1 | 2 | 40 | 55 | 20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |